Skip to main content
Jonathan Rothberg, MD, Internal Medicine, Medford, MA

Jonathan D. Rothberg MD


Physician

Join to View Full Profile
  • 101 Main StSte 116Medford, MA 02155

  • Phone+1 781-396-2000

  • Fax+1 781-395-0759

Are you Dr. Rothberg?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Jonathan Rothberg, MD is a board certified internist in Medford, Massachusetts. He is currently licensed to practice medicine in Massachusetts.

Education & Training

  • Newton-Wellesley Hospital
    Newton-Wellesley HospitalResidency, Internal Medicine, 1997 - 2000
  • Stony Brook Medicine
    Stony Brook MedicineInternship, Transitional Year, 1996 - 1997
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1996
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1996

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2000 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Press Mentions

  • Butterfly Network and Rutgers Robert Wood Johnson Medical School Reveal Preliminary Findings from Seminal Study on Impact of POCUS in Hospital Care
    Butterfly Network and Rutgers Robert Wood Johnson Medical School Reveal Preliminary Findings from Seminal Study on Impact of POCUS in Hospital CareJanuary 13th, 2025
  • Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a Thrombectomy
    Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a ThrombectomyFebruary 9th, 2023
  • AI Therapeutics Announces the Acquisition of Novel Cancer Drug Candidate EC-8042 (AIT-102)
    AI Therapeutics Announces the Acquisition of Novel Cancer Drug Candidate EC-8042 (AIT-102)April 24th, 2022
  • Join now to see all